Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen Paemeleire

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
The Journal of Headache and Pain|February 9, 2011
Does visual cortex lactate increase following photic stimulation in migraine without aura patients? A functional (1)H-MRS studyHarmen Reyngoudt, Koen Paemeleire, Anneloor Dierickx, et al.
The Journal of Headache and Pain|August 24, 2021
Structured headache services as the solution to the ill-health burden of headache. 2. Modelling effectiveness and cost-effectiveness of implementation in Europe: methodologyMichela Tinelli, Matilde Leonardi, Koen Paemeleire, et al.
The Journal of Headache and Pain|October 26, 2021
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugsFenne Vandervorst, Laura Van Deun, Annelies Van Dycke, et al.
BMC Medical Informatics and Decision Making|February 19, 2025
Uncovering the potential of smartphones for behavior monitoring during migraine follow-upMarija Stojchevska, Jonas Van Der Donckt, Nicolas Vandenbussche, et al.
The Journal of Headache and Pain|August 12, 2021
Structured headache services as the solution to the ill-health burden of headache. 3. Modelling effectiveness and cost-effectiveness of implementation in Europe: findings and conclusionsMichela Tinelli, Matilde Leonardi, Koen Paemeleire, et al.
The Journal of Headache and Pain|July 16, 2013
Genes and primary headaches: discovering new potential therapeutic targetsInnocenzo Rainero, Elisa Rubino, Koen Paemeleire, et al.
Cephalalgia : an International Journal of Headache|April 16, 2019
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled studyPeter J Goadsby, Koen Paemeleire, Gregor Broessner, et al.
The Journal of Headache and Pain|February 13, 2025
Analysis of free-living daytime movement in patients with migraine with access to acute treatmentJonas Van Der Donckt, Nicolas Vandenbussche, Mathias De Brouwer, et al.
The Journal of Headache and Pain|August 5, 2020
Efficacy and safety of erenumab in women with a history of menstrual migraineJelena M Pavlovic, Koen Paemeleire, Hartmut Göbel, et al.
Neurology International|March 26, 2025
Tracking Migraine Symptoms: A Longitudinal Comparison of Smartphone-Based Headache Diaries and Clinical InterviewsNicolas Vandenbussche, Jonas Van Der Donckt, Mathias De Brouwer, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Headache and Pain|February 9, 2011
Does visual cortex lactate increase following photic stimulation in migraine without aura patients? A functional (1)H-MRS studyHarmen Reyngoudt, Koen Paemeleire, Anneloor Dierickx, et al.
The Journal of Headache and Pain|August 24, 2021
Structured headache services as the solution to the ill-health burden of headache. 2. Modelling effectiveness and cost-effectiveness of implementation in Europe: methodologyMichela Tinelli, Matilde Leonardi, Koen Paemeleire, et al.
The Journal of Headache and Pain|October 26, 2021
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugsFenne Vandervorst, Laura Van Deun, Annelies Van Dycke, et al.
BMC Medical Informatics and Decision Making|February 19, 2025
Uncovering the potential of smartphones for behavior monitoring during migraine follow-upMarija Stojchevska, Jonas Van Der Donckt, Nicolas Vandenbussche, et al.
The Journal of Headache and Pain|August 12, 2021
Structured headache services as the solution to the ill-health burden of headache. 3. Modelling effectiveness and cost-effectiveness of implementation in Europe: findings and conclusionsMichela Tinelli, Matilde Leonardi, Koen Paemeleire, et al.
The Journal of Headache and Pain|July 16, 2013
Genes and primary headaches: discovering new potential therapeutic targetsInnocenzo Rainero, Elisa Rubino, Koen Paemeleire, et al.
Cephalalgia : an International Journal of Headache|April 16, 2019
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled studyPeter J Goadsby, Koen Paemeleire, Gregor Broessner, et al.
The Journal of Headache and Pain|February 13, 2025
Analysis of free-living daytime movement in patients with migraine with access to acute treatmentJonas Van Der Donckt, Nicolas Vandenbussche, Mathias De Brouwer, et al.
The Journal of Headache and Pain|August 5, 2020
Efficacy and safety of erenumab in women with a history of menstrual migraineJelena M Pavlovic, Koen Paemeleire, Hartmut Göbel, et al.
Neurology International|March 26, 2025
Tracking Migraine Symptoms: A Longitudinal Comparison of Smartphone-Based Headache Diaries and Clinical InterviewsNicolas Vandenbussche, Jonas Van Der Donckt, Mathias De Brouwer, et al.
Pageof 8